143 related articles for article (PubMed ID: 35209855)
1. Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.
Wang X; Hu B; Chen J; Xie F; Han D; Zhao Q; Sun H; Fu C; Liu C; Wang Z; Lin H; Huang W
BMC Cancer; 2022 Feb; 22(1):207. PubMed ID: 35209855
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma.
Hu B; Jia F; Zhou H; Zhou T; Zhao Q; Chen Y; Li B; Huang W
J Cancer; 2020; 11(12):3693-3700. PubMed ID: 32284766
[No Abstract] [Full Text] [Related]
3. Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy.
Wang S; Zhang C; Wang Y; Luo K; Yang Y; Yang Y; Liu S; Li Q; Xi M
Esophagus; 2022 Oct; 19(4):660-669. PubMed ID: 35419642
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
5. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.
Kim JW; Kim TH; Kim JH; Lee IJ
World J Gastroenterol; 2018 Feb; 24(7):862-869. PubMed ID: 29467556
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Esophageal Fistula in Esophageal Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
Zhu C; Wang S; You Y; Nie K; Ji Y
Oncol Res Treat; 2020; 43(1-2):34-41. PubMed ID: 31639800
[TBL] [Abstract][Full Text] [Related]
8. Relationship between nutritional status and esophageal fistula formation after radiotherapy for esophageal cancer.
Watanabe S; Ogino I; Kunisaki C; Hata M
Cancer Radiother; 2019 Jun; 23(3):222-227. PubMed ID: 31133512
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors.
Shioyama Y; Nakamura K; Ohga S; Nomoto S; Sasaki T; Yamaguchi T; Toba T; Yoshitake T; Terashima H; Honda H
Jpn J Clin Oncol; 2007 Dec; 37(12):918-23. PubMed ID: 18211982
[TBL] [Abstract][Full Text] [Related]
10. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
11. Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
Pao TH; Chen YY; Chang WL; Chang JS; Chiang NJ; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
PLoS One; 2021; 16(5):e0251811. PubMed ID: 33989365
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
Tsushima T; Mizusawa J; Sudo K; Honma Y; Kato K; Igaki H; Tsubosa Y; Shinoda M; Nakamura K; Fukuda H; Kitagawa Y;
Medicine (Baltimore); 2016 May; 95(20):e3699. PubMed ID: 27196482
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
14. Esophageal fistula associated with intracavitary irradiation for esophageal carcinoma.
Hishikawa Y; Tanaka S; Miura T
Radiology; 1986 May; 159(2):549-51. PubMed ID: 3961189
[TBL] [Abstract][Full Text] [Related]
15. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
16. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
17. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Ishihara R; Yamamoto S; Iishi H; Takeuchi Y; Sugimoto N; Higashino K; Uedo N; Tatsuta M; Yano M; Imai A; Nishiyama K
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):123-9. PubMed ID: 19386426
[TBL] [Abstract][Full Text] [Related]
18. Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.
Taggar AS; Pitter KL; Cohen GN; Schattner M; Gerdes H; Markowitz AJ; Ilson D; Brady P; Cuaron JJ; Goodman KA; Wu AJ
Brachytherapy; 2018; 17(3):621-627. PubMed ID: 29496425
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
20. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
